scFv-Based "Grababody" as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-12-3920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeted Enhancement of hERG K+ Channel Activity With scFv Antibody Fragments

Biophysical Journal
Biophysics
2016English

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery
Oncology
2015English

Exploitation of Synthetic mRNA to Drive Immune Effector Cell Recruitment and Functional Reprogramming in Vivo

Journal of Immunology
AllergyImmunology
2018English

Targeting Dendritic Cells: A Promising Strategy to Improve Vaccine Effectiveness

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

Generation and Immune-Characterization of Single Chain Fragment Variable (scFv) Antibody Recognize Breast Cancer Cells Line (MCF-7)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Cytotoxicity of Cytokine‑induced Killer Cells Targeted by a Bispecific Antibody to Gastric Cancer Cells

Oncology Letters
Cancer ResearchOncology
2013English

A General Approach to Antibody Thermostabilization

mAbs
AllergyImmunology
2014English

The Salmonella Translocated Effector SopA Is Targeted to the Mitochondria of Infected Cells

Journal of Bacteriology
MicrobiologyMolecular Biology
2005English

Simulation-Based Engineering of Humanized SCFV Antibody Against hTNF-α

Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy